@ARTICLE{
author={Cassidy Jonathan|,Douillard Y|,Twelves C|,McKendrick JJ|,Scheithauer W|,Bustova I|,Johnston PG|,Lesniewski-Kmak L|,Jelic Svetislav B|,Fountzilas George|,Coxon F|,Diaz-Rubio E|,Maughan TS|,Malzyner A|,Bertetto O|,Beham A|,Figer A|,Dufour P|,Patel KK|,Cowell|},
year={2006},
title={Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial},
journal={BRITISH JOURNAL OF CANCER},
volume={94},
number={8},
pages={1122-1129},
document_type={Article},
}